Health Sciences Acquisitions Corporation 2 reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.685791 million compared to USD 0.090411 million a year ago. Basic loss per share from continuing operations was USD 0.05.
For the nine months, net loss was USD 1.86 million compared to USD 0.290742 million a year ago. Basic loss per share from continuing operations was USD 0.1 compared to USD 0.01 a year ago.